Hartford Investment Management Co. Cuts Stake in Humana Inc (HUM)

Hartford Investment Management Co. decreased its stake in Humana Inc (NYSE:HUM) by 8.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 42,742 shares of the insurance provider’s stock after selling 3,747 shares during the period. Hartford Investment Management Co.’s holdings in Humana were worth $8,811,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Hermes Investment Management Ltd. increased its stake in Humana by 13.1% in the third quarter. Hermes Investment Management Ltd. now owns 235,438 shares of the insurance provider’s stock valued at $41,647,000 after buying an additional 27,293 shares during the period. APG Asset Management N.V. increased its stake in Humana by 6.0% in the third quarter. APG Asset Management N.V. now owns 194,678 shares of the insurance provider’s stock valued at $34,437,000 after buying an additional 11,100 shares during the period. Thrivent Financial for Lutherans increased its stake in Humana by 6.3% in the fourth quarter. Thrivent Financial for Lutherans now owns 6,065 shares of the insurance provider’s stock valued at $1,235,000 after buying an additional 360 shares during the period. Principal Financial Group Inc. increased its stake in Humana by 4.5% in the third quarter. Principal Financial Group Inc. now owns 244,429 shares of the insurance provider’s stock valued at $43,237,000 after buying an additional 10,562 shares during the period. Finally, Chicago Equity Partners LLC increased its stake in Humana by 157.7% in the third quarter. Chicago Equity Partners LLC now owns 59,210 shares of the insurance provider’s stock valued at $10,474,000 after buying an additional 36,230 shares during the period. Institutional investors own 93.00% of the company’s stock.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Humana Inc (NYSE:HUM) opened at 227.89 on Friday. Humana Inc has a one year low of $150.00 and a one year high of $233.66. The firm has a market cap of $32.89 billion, a PE ratio of 23.23 and a beta of 0.91. The firm has a 50-day moving average price of $219.76 and a 200-day moving average price of $207.67.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, May 3rd. The insurance provider reported $2.75 EPS for the quarter, beating the Zacks’ consensus estimate of $2.55 by $0.20. Humana had a net margin of 1.09% and a return on equity of 13.09%. The firm had revenue of $13.76 billion during the quarter, compared to the consensus estimate of $13.61 billion. During the same quarter last year, the firm earned $1.86 EPS. On average, equities analysts expect that Humana Inc will post $11.14 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 31st. Investors of record on Friday, June 30th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date of this dividend is Wednesday, June 28th. Humana’s payout ratio is 29.59%.

TRADEMARK VIOLATION WARNING: “Hartford Investment Management Co. Cuts Stake in Humana Inc (HUM)” was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://transcriptdaily.com/2017/05/20/hartford-investment-management-co-sells-3747-shares-of-humana-inc-hum-updated-updated-updated.html.

A number of analysts have recently weighed in on HUM shares. Jefferies Group LLC reiterated a “buy” rating and set a $237.00 target price on shares of Humana in a research report on Friday, March 24th. Deutsche Bank AG started coverage on Humana in a research report on Wednesday, April 5th. They set a “hold” rating and a $216.00 target price for the company. Bank of America Corp started coverage on Humana in a research report on Friday, January 27th. They set a “buy” rating for the company. Evercore ISI reiterated an “overweight” rating on shares of Humana in a research report on Monday, February 27th. Finally, Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $237.00 target price for the company in a research report on Tuesday, April 18th. Nine equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $215.25.

In related news, SVP Jody L. Bilney sold 4,600 shares of the stock in a transaction dated Friday, May 5th. The shares were sold at an average price of $230.16, for a total value of $1,058,736.00. Following the completion of the transaction, the senior vice president now owns 8,978 shares of the company’s stock, valued at approximately $2,066,376.48. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO James E. Murray sold 70,332 shares of the stock in a transaction dated Tuesday, February 21st. The shares were sold at an average price of $205.20, for a total transaction of $14,432,126.40. Following the completion of the transaction, the chief operating officer now directly owns 76,798 shares of the company’s stock, valued at approximately $15,758,949.60. The disclosure for this sale can be found here. In the last ninety days, insiders sold 456,402 shares of company stock valued at $96,803,127. 0.50% of the stock is owned by insiders.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

12 Month Chart for NYSE:HUM

Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply